• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Early Anticoagulation Strategies Comparable After Afib-Related Stroke (CME/CE)
(MedPage Today) -- NOAC, warfarin show similar safety and efficacy after mild acute ischemic stroke
Source: MedPage Today Cardiovascular - September 11, 2017 Category: Cardiology Source Type: news

Warfarin Cuts Afib Stroke Risk Down to Normal (CME/CE)
(MedPage Today) -- Residual stroke risk similar to that of non-afib population
Source: MedPage Today Cardiovascular - May 6, 2016 Category: Cardiology Source Type: news

Study: Warfarin Still a Good Option for Afib Stroke Prevention (CME/CE)
(MedPage Today) -- But others warn against using these Swedish registry data to guide tx
Source: MedPage Today Cardiovascular - April 21, 2016 Category: Cardiology Source Type: news

Warfarin Discontinuation Increases Stroke Risk (CME/CE)
(MedPage Today) -- Afib patients face doubled risk for at least a year after stopping drug
Source: MedPage Today Cardiovascular - September 2, 2015 Category: Cardiology Source Type: news

ESC: Warfarin Discontinuation Increases Stroke Risk (CME/CE)
(MedPage Today) -- Afib patients face doubled risk for at least a year after stopping drug
Source: MedPage Today Cardiovascular - September 2, 2015 Category: Cardiology Source Type: news

Stroke Rounds: Oral Anticoagulants and Brain Bleeds (CME/CE)
(MedPage Today) -- Study suggests warfarin or NOACs may reduce recurrent ICH
Source: MedPage Today Cardiovascular - June 16, 2015 Category: Cardiology Source Type: news

Stroke Rounds: Watchman Proves Long-Term Mettle in AFib (CME/CE)
(MedPage Today) -- The percutaneous left atrial appendage closure device did better than warfarin.
Source: MedPage Today Cardiovascular - November 18, 2014 Category: Cardiology Source Type: news

Stroke Rounds: Fewer Strokes in High-Risk Patients
(MedPage Today) -- Ischemic stroke rates dropped as warfarin use increased among Medicare beneficiaries over a 19-year period -- even among groups that have not been well represented in clinical trials, including the elderly, women, and blacks, researchers found.
Source: MedPage Today Cardiovascular - June 24, 2014 Category: Cardiology Source Type: news

Start Warfarin, Have a Stroke? (CME/CE)
(MedPage Today) -- Starting warfarin for preventing stroke in patients with atrial fibrillation appeared to be associated with a transiently increased risk of ischemic stroke before the preventive effects kicked in, a large case-control study showed.
Source: MedPage Today Cardiovascular - December 20, 2013 Category: Cardiology Source Type: news

AHA: Choosing an Anticoagulant Just Got Tougher
DALLAS (MedPage Today) -- With a possible fourth new oral anticoagulant nipping at the heels of warfarin, how should physicians choose among the options for stroke prevention in atrial fibrillation? Leading cardiologists offered their approach.
Source: MedPage Today Cardiovascular - November 21, 2013 Category: Cardiology Source Type: news

AHA: Another Anticoagulant Bests Warfarin in Afib (CME/CE)
(MedPage Today) -- The novel oral factor Xa inhibitor edoxaban prevented stroke as well as warfarin but did so with lower risk in nonvalvular atrial fibrillation, a randomized trial showed.
Source: MedPage Today Cardiovascular - November 20, 2013 Category: Cardiology Source Type: news

Novel Anticoagulant Bests Warfarin in Afib (CME/CE)
(MedPage Today) -- The novel oral factor Xa inhibitor edoxaban prevented stroke as well as warfarin but did so with lower risk in nonvalvular atrial fibrillation, a randomized trial showed.
Source: MedPage Today Cardiovascular - November 20, 2013 Category: Cardiology Source Type: news

New Drugs Better Value Than Warfarin (CME/CE)
(MedPage Today) -- The three newest anticoagulants -- dabigatran (Pradaxa), apixaban (Eliquis), and rivaroxaban (Xarelto) -- are cost-effective relative to warfarin for preventing stroke in patients with nonvalvular atrial fibrillation, researchers found.
Source: MedPage Today Cardiovascular - April 9, 2013 Category: Cardiology Source Type: news

Switching Drugs Tricky for Stroke in AF (CME/CE)
(MedPage Today) -- Stopping rivaroxaban (Xarelto) doesn't appear to be worse for atrial fibrillation patients than stopping warfarin, but switching from rivaroxaban to warfarin can be problematic, a ROCKET AF trial analysis suggested.
Source: MedPage Today Cardiovascular - February 5, 2013 Category: Cardiology Source Type: news